Mild taste with little to no aftertaste
But dont forget the 503A exception: These small operations can legally keep mixing compounded GLP-1s outside of a shortage provided theyve tweaked their version in a way that makes a significant difference for the patientfor instance, switching the dose or adding or removing an ingredient for a medical reason specified by a prescriber
For some people, discontinuing GLP-1s may make sense, but for most usersespecially those with ongoing obesity or metabolic diseaselonger-term treatment may be helpful
On one hand, fatty acids produced from triglycerides by lipolysis can be used as an energy source by many tissues, including muscle cells (Hargreaves and Spriet, 2020)
GLP-1 and GIP inhibitors are amazing medications at doing what they were developed for managing blood sugar in people with type 2 diabetes and weight loss in obesity, study co-author Kelly Allison, a professor of psychiatry and director of the Center for Weight and Eating Disorders at Penn, said in the news release